BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
110.23
+1.43 (1.31%)
At close: Feb 27, 2026, 4:00 PM EST
111.00
+0.77 (0.70%)
After-hours: Feb 27, 2026, 6:00 PM EST
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
$546,192
Profits / Employee
-$99,034
Market Cap
27.66B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | 1,310 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| BeOne Medicines AG | 11,000 |
| Moderna | 4,700 |
| Genmab | 2,973 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| argenx SE | 1,599 |
| Ascendis Pharma | 1,189 |
BNTX News
- 3 days ago - BioNTech: The Market Is Pricing Low Oncology Success - Seeking Alpha
- 4 days ago - BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 - GlobeNewsWire
- 9 days ago - BioNTech sues Moderna for patent infringement over COVID-19 shots - Reuters
- 4 weeks ago - BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer - GlobeNewsWire
- 6 weeks ago - BioNTech SE (BNTX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 6 weeks ago - BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - University of Pennsylvania, BioNTech, and OUP Launch $50 Million Life Sciences Fund - Business Wire
- 2 months ago - BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field - GlobeNewsWire